These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Panel rejects calls for routine screening for ovarian cancer, cites role for paclitaxel. Am J Hosp Pharm; 1994 Jun; 51(11):1381-2. PubMed ID: 7942870 [No Abstract] [Full Text] [Related]
5. Patient page #63. Ovarian cancer. What you need to know! J Okla State Med Assoc; 2005 Sep; 98(9):466-7. PubMed ID: 16295981 [No Abstract] [Full Text] [Related]
6. Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer. Andersen MR; Peacock S; Nelson J; Wilson S; McIntosh M; Drescher C; Urban N Gynecol Oncol; 2002 Apr; 85(1):3-8. PubMed ID: 11925113 [TBL] [Abstract][Full Text] [Related]
7. The National Cancer Institute Multi-Screening Trial. Prorok P Can J Oncol; 1994 Nov; 4 Suppl 1():98-9; discussion 100-1. PubMed ID: 8853500 [No Abstract] [Full Text] [Related]
8. Clinical and laboratory directions for ovarian cancer research. Bast RC Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S164-7. PubMed ID: 7835802 [No Abstract] [Full Text] [Related]
11. National Institutes of Health Consensus Development Conference Statement. Ovarian cancer: screening, treatment, and follow-up. Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S4-14. PubMed ID: 7835809 [TBL] [Abstract][Full Text] [Related]
12. Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines. Beckmann MW; Schnürch HG; Bodden-Heidrich R; Mosny DS; Crombach G; Nitz U; Achnoula M; Bender HG Eur J Cancer Prev; 1996 Dec; 5(6):468-75. PubMed ID: 9061278 [TBL] [Abstract][Full Text] [Related]
13. The value of cancer antigen 125 (CA 125) during treatment and follow-up of patients with ovarian cancer. de Bruijn HW; van der Zee AG; Aalders JG Curr Opin Obstet Gynecol; 1997 Feb; 9(1):8-13. PubMed ID: 9090475 [TBL] [Abstract][Full Text] [Related]
14. Making decisions about screening for ovarian cancer. Mass screening may not prove to be sound public health policy. Bell R BMJ; 2000 Apr; 320(7239):940; author reply 940-1. PubMed ID: 10787261 [No Abstract] [Full Text] [Related]
15. Epidemiology and screening of ovarian cancer. Tortolero-Luna G; Mitchell MF; Rhodes-Morris HE Obstet Gynecol Clin North Am; 1994 Mar; 21(1):1-23. PubMed ID: 8015758 [TBL] [Abstract][Full Text] [Related]
16. [Problem of uterine and ovarian cancer mass screening]. Ohmura M; Oda M Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389 [TBL] [Abstract][Full Text] [Related]
17. [New advances in screening and treatment of ovarian cancer]. Morice P; Pautier P; Bidart JM Bull Cancer; 2003 Jan; 90(1):53-60. PubMed ID: 12609805 [TBL] [Abstract][Full Text] [Related]
18. Ovarian intraepithelial neoplasia and ovarian cancer. Gershenson DM; Tortolero-Luna G; Malpica A; Baker VV; Whittaker L; Johnson E; Follen Mitchell M Obstet Gynecol Clin North Am; 1996 Jun; 23(2):475-543. PubMed ID: 8784888 [TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of the Stockholm screening study on ovarian cancer. Einhorn N; Bast R; Knapp R; Nilsson B; Zurawski V; Sjövall K Gynecol Oncol; 2000 Dec; 79(3):466-70. PubMed ID: 11104621 [TBL] [Abstract][Full Text] [Related]